Cargando…

Management of Acute Myeloid Leukemia: A Review for General Practitioners in Oncology

Acute myeloid leukemia (AML) is a hematologic malignancy that most frequently develops in older adults. Overall, AML is associated with a high mortality although advancements in genetic risk stratification and new treatments are leading to improvements in outcomes for some subgroups. In this review,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stubbins, Ryan J., Francis, Annabel, Kuchenbauer, Florian, Sanford, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498246/ https://www.ncbi.nlm.nih.gov/pubmed/36135060 http://dx.doi.org/10.3390/curroncol29090491

Ejemplares similares

FLAMSA-RIC for Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes: A Systematic Review and Meta-Analysis
por: Owattanapanich, Weerapat, et al.
Publicado: (2019)

Management of Multiple Myeloma: A Review for General Practitioners in Oncology
por: Monteith, Bethany E., et al.
Publicado: (2023)

Meningioma 1 is indispensable for mixed lineage leukemia-rearranged acute myeloid leukemia
por: Sharma, Amit, et al.
Publicado: (2020)

Maintenance With Hypomethylating Agents After Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis
por: Kungwankiattichai, Smith, et al.
Publicado: (2022)

Differentiation therapy for myeloid malignancies: beyond cytotoxicity
por: Stubbins, Ryan J., et al.
Publicado: (2021)

Updates on the Management of Acute Myeloid Leukemia
por: Huerga-Domínguez, Sofía, et al.
Publicado: (2022)

The Immuno-Oncology and Genomic Aspects of DNA-Hypomethylating Therapeutics in Acute Myeloid Leukemia
por: Urabe, Akiko, et al.
Publicado: (2023)

Acute Myeloid Leukemia: Aging and Epigenetics
por: Zjablovskaja, Polina, et al.
Publicado: (2019)

Update on Optimal Management of Acute Myeloid Leukemia
por: El Rassi, Fuad, et al.
Publicado: (2013)

Role of Biomarkers in the Management of Acute Myeloid Leukemia
por: Small, Sara, et al.
Publicado: (2022)

Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia
por: Hirsch, Susanne, et al.
Publicado: (2017)

Glasdegib plus low-dose cytarabine for acute myeloid leukemia: Practical considerations from advanced practitioners and pharmacists
por: Relias, Valerie, et al.
Publicado: (2020)

Practical Considerations for the Management of Cancer-Associated Venous Thromboembolism: A Guide for the General Oncology Practitioner
por: Harrigan, Amye M., et al.
Publicado: (2022)

Non-Small-Cell Lung Cancer in 2022: A Review for General Practitioners in Oncology
por: Mithoowani, Hamid, et al.
Publicado: (2022)

Acute Myeloid Leukemia: A Concise Review
por: Saultz, Jennifer N., et al.
Publicado: (2016)

Oncology training programmes for general practitioners: a scoping review
por: Gyawali, Bishal, et al.
Publicado: (2021)

The Role of Dental Practitioners in the Management of Oncology Patients: The Head and Neck Radiation Oncology Patient and the Medical Oncology Patient
por: Owosho, Adepitan A., et al.
Publicado: (2023)

Acute Myeloid Leukemia: Is It T Time?
por: Khoud, Meriem Ben, et al.
Publicado: (2021)

Practical Management of the Venetoclax-Treated Patient in Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
por: Waggoner, Matthew, et al.
Publicado: (2022)

Recent Advances in the Management of Pediatric Acute Myeloid Leukemia—Report of the Hungarian Pediatric Oncology-Hematology Group
por: Gaál, Zsuzsanna, et al.
Publicado: (2021)

Management of Acute Myeloid Leukemia: Current Treatment Options and Future Perspectives
por: Fleischmann, Maximilian, et al.
Publicado: (2021)

Paradigm Shift in the Management of Acute Myeloid Leukemia—Approved Options in 2023
por: Premnath, Naveen, et al.
Publicado: (2023)

Classification of acute myeloid leukemia
por: Hwang, Sang Mee
Publicado: (2020)

Management of allergic rhinitis in general practitioners
por: Wang, De Yun
Publicado: (2012)

Tipifarnib in the treatment of acute myeloid leukemia
por: Thomas, Xavier, et al.
Publicado: (2007)

Differentiation Therapy of Acute Myeloid Leukemia
por: Gocek, Elzbieta, et al.
Publicado: (2011)

Comparative proteomics in acute myeloid leukemia
por: Luczak, Magdalena, et al.
Publicado: (2012)

Precision therapy for acute myeloid leukemia
por: Yang, Xue, et al.
Publicado: (2018)

Novel Agents for Acute Myeloid Leukemia
por: Luppi, Mario, et al.
Publicado: (2018)

Metabolic Plasticity of Acute Myeloid Leukemia
por: Kreitz, Johanna, et al.
Publicado: (2019)

miRNAs in acute myeloid leukemia
por: Liao, Qiong, et al.
Publicado: (2016)

Emerging therapies for acute myeloid leukemia
por: Saygin, Caner, et al.
Publicado: (2017)

Therapies for acute myeloid leukemia: vosaroxin
por: Sayar, Hamid, et al.
Publicado: (2017)

Molecular targeting in acute myeloid leukemia
por: Lim, Seah H., et al.
Publicado: (2017)

HDAC Inhibitors in Acute Myeloid Leukemia
por: San José-Enériz, Edurne, et al.
Publicado: (2019)

Emerging Immunotherapy for Acute Myeloid Leukemia
por: Tabata, Rikako, et al.
Publicado: (2021)

Chromosomal Instability in Acute Myeloid Leukemia
por: de Oliveira Lisboa, Mateus, et al.
Publicado: (2021)

RSK Isoforms in Acute Myeloid Leukemia
por: Youn, Minyoung, et al.
Publicado: (2021)

Molecular testing for acute myeloid leukemia
por: Qin, Dahui
Publicado: (2022)

Circular RNAs in acute myeloid leukemia
por: Singh, Vijendra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d9avpe0aauiudb4r9d428fj4ak